Amanta Healthcare Limited has intimated the National Stock Exchange of India Limited and BSE Limited about an upcoming Board of Directors meeting. The meeting is scheduled to be held on Tuesday, November 3, 2026. The primary agenda is to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026.
Regarding the trading window closure, the company refers to its earlier intimation dated September 24, 2026. The trading window was closed from Thursday, October 1, 2026, in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended. The window is scheduled to reopen on Friday, November 6, 2026.
The disclosure is signed by Nikhita Dinodia, Company Secretary & Compliance Officer, and includes her digital signature details with timestamp: 2026.10.26 12:40:00 +05'30'.
The company's Corporate Identification Number (CIN) is L24139GJ1994PLC023944.